Monday January 20th, 2020 9:37PM

AP Health - Men's Health

Dendreon Signs Union City Lease Agreement
UNION CITY, Ga.--(BUSINESS WIRE)--Dec 18, 2019--Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, has signed a 10-year lease agree...
9:01AM ( 1 month ago )
SCUFMO: Scuf Gaming and Movember Join Forces With Top Streamers to Change the Game for Men’s Health
ATLANTA--(BUSINESS WIRE)--Nov 1, 2019-- , innovator and creator of high-performance gaming controllers, today announced its collaboration with the global charity Movember for #SCUFMO,...
1:00PM ( 2 months ago )
Dementia tied to hormone-blocking prostate cancer treatment
Alzheimer's disease may be a risk for older prostate cancer patients given hormone-blocking treatment
1:36PM ( 6 months ago )
Medicaid bought sex offenders' erectile dysfunction drugs
New York's publicly funded Medicaid program paid for $63,000 worth of erectile dysfunction drugs for sex offenders, despite state prohibition
10:03AM ( 7 months ago )
Drugs make headway against lung, breast, prostate cancers
Newer drugs are improving survival for some people with hard-to-treat forms of cancer
5:12PM ( 7 months ago )
Correction: Cancer Drugs story
Correction: Cancer Drugs story
2:01PM ( 7 months ago )
Judge calls insurer 'barbaric' for denying cancer therapy
A federal judge in Miami recused himself from a case, saying he can't be impartial in deciding a lawsuit challenging a health insurance provider over denial of coverage for a patient who sought proton beam therapy as treatment for prostate cancer
9:45AM ( 8 months ago )
Potential 2020 candidate Bennet says he has prostate cancer
Democratic Sen. Michael Bennet of Colorado says he has been diagnosed with prostate cancer as he considers a 2020 Democratic presidential bid
10:05PM ( 9 months ago )
Another infant boy in Italy dies after home circumcision
The news agency ANSA reports the death of another infant boy in Italy as the result of a circumcision performed at home
7:37AM ( 9 months ago )
OncoCell Announces Late-Breaking Poster Presentation at AACR 2019 on a Noninvasive Blood-Based Assay for Prostate Cancer Prognosis
ATLANTA--(BUSINESS WIRE)--Apr 1, 2019--OncoCell MDx, a company developing novel noninvasive diagnostic and prognostic tests, will present results from a feasibility study of a new prostate cancer prog...
2:28PM ( 9 months ago )